JP2006051019A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006051019A5 JP2006051019A5 JP2005197432A JP2005197432A JP2006051019A5 JP 2006051019 A5 JP2006051019 A5 JP 2006051019A5 JP 2005197432 A JP2005197432 A JP 2005197432A JP 2005197432 A JP2005197432 A JP 2005197432A JP 2006051019 A5 JP2006051019 A5 JP 2006051019A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- epp2
- epitope
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 37
- 229920001184 polypeptide Polymers 0.000 claims 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims 20
- 239000002773 nucleotide Substances 0.000 claims 10
- 125000003729 nucleotide group Chemical group 0.000 claims 10
- 239000002157 polynucleotide Substances 0.000 claims 5
- 102000040430 polynucleotide Human genes 0.000 claims 5
- 108091033319 polynucleotide Proteins 0.000 claims 5
- 239000000523 sample Substances 0.000 claims 5
- 201000009273 Endometriosis Diseases 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 230000009870 specific binding Effects 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000013068 control sample Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/887,540 US20060008876A1 (en) | 2004-07-07 | 2004-07-07 | ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006051019A JP2006051019A (ja) | 2006-02-23 |
| JP2006051019A5 true JP2006051019A5 (enExample) | 2007-07-12 |
Family
ID=35124497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005197432A Pending JP2006051019A (ja) | 2004-07-07 | 2005-07-06 | Ｍｅ−５、ｍｅ−２、及びｅｐｐ２：子宮内膜症に罹患している女性の血清中に存在する自己抗体と反応するヒト蛋白質抗原 |
Country Status (9)
| Country | Link |
|---|---|
| US (7) | US20060008876A1 (enExample) |
| EP (1) | EP1614692B1 (enExample) |
| JP (1) | JP2006051019A (enExample) |
| AT (1) | ATE433462T1 (enExample) |
| AU (1) | AU2005202925A1 (enExample) |
| CA (1) | CA2509632A1 (enExample) |
| DE (1) | DE602005014828D1 (enExample) |
| ES (1) | ES2326324T3 (enExample) |
| NZ (1) | NZ541063A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8329399B2 (en) * | 2006-10-27 | 2012-12-11 | Siu K W Michael | Endometrial biomarkers |
| US8279789B2 (en) * | 2008-06-10 | 2012-10-02 | Qualcomm Incorporated | Intelligent setting of hysteresis activation timer to enter hysteresis sooner and save battery |
| WO2011085213A2 (en) * | 2010-01-07 | 2011-07-14 | Sanford-Burnham Medical Research Institute | Pathologically-activated therapeutics |
| DE102012002929A1 (de) | 2012-02-14 | 2013-08-14 | Jürgen Lewald | Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose |
| GB202310300D0 (en) | 2023-07-05 | 2023-08-16 | Univ Edinburgh | Endometrosis markers and methods of diagnosing nedometriosis |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US652187A (en) * | 1899-11-02 | 1900-06-19 | Sigvald Krohn | System of electrical distribution. |
| US4489166A (en) * | 1982-05-27 | 1984-12-18 | Research Corporation | Monitoring of human endometrial function by radioimmunoassay of PEP |
| AU5068090A (en) | 1989-03-07 | 1990-09-13 | Adeza Biomedical Corporation | Endometriosis diagnosis methods and reagents |
| US5302738A (en) | 1991-03-15 | 1994-04-12 | Hoffmann-La Roche Inc. | Chiral phosphines |
| CA2062675A1 (en) | 1991-04-09 | 1992-10-10 | Sandra S. Fenton | Endometrial antigen, composition, test kit and method for endometrial antibody determination |
| WO1994028021A1 (en) * | 1993-05-28 | 1994-12-08 | Medical University Of South Carolina | Endometrial proteins, antigenic compositions and methods for detecting endometriosis |
| US5877284A (en) * | 1993-08-12 | 1999-03-02 | The Trustees Of The University Of Pennsylvania | Isolated chemotactic factor from patients with endometriosis |
| US7122322B2 (en) * | 1994-10-25 | 2006-10-17 | The Curators Of The University Of Missouri | Endometriosis-specific secretory protein |
| US6531277B2 (en) * | 1994-10-25 | 2003-03-11 | The Curators Of The University Of Missouri | Endometriosis-specific secretory protein |
| US5843673A (en) * | 1994-10-25 | 1998-12-01 | Curators Of The University Of Missouri | Method of screening for endometriosis |
| US5618680A (en) * | 1994-12-28 | 1997-04-08 | Institut De Medecine De La Reproduction De Montreal | Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis |
| US6376201B2 (en) * | 1994-12-28 | 2002-04-23 | Procrea Biosciences Inc. | Use of ligands specific to major histocompatibility complex-class I antigens for diagnosing endometriosis |
| WO1997035016A1 (en) | 1996-03-18 | 1997-09-25 | Novo Nordisk Biotech Inc | Polypeptides having phytase activity and nucleic acids encoding same |
| WO1997035018A1 (en) | 1996-03-21 | 1997-09-25 | New York University | Growth factor inducible serine/threonine phosphatase fin13 |
| US6294662B1 (en) * | 1996-08-27 | 2001-09-25 | University Of South Florida | Nucleic acids encoding an endometrial bleeding associated factor (ebaf) |
| WO1999004265A2 (en) | 1997-07-17 | 1999-01-28 | Ludwig Institute For Cancer Research | Cancer associated nucleic acids and polypeptides |
| US6165767A (en) * | 1998-03-20 | 2000-12-26 | Incyte Pharmaceuticals, Inc. | Protein phosphatase-related molecules |
| AU760613B2 (en) | 1998-06-04 | 2003-05-22 | Reprogen, Inc. | Use of prothymosin in the diagnosis and treatment of endometriosis |
| AU765750B2 (en) * | 1998-06-04 | 2003-09-25 | Reprogen, Inc. | Use of cathepsin s in the diagnosis and treatment of endometriosis |
| US6525187B1 (en) * | 1998-07-31 | 2003-02-25 | Diagnostic Products Corporation | Polynucleotide encoding autoantigens associated with endometriosis |
| ATE374370T1 (de) | 1999-01-25 | 2007-10-15 | Siemens Medical Solutions Diag | Verfahren zur diagnose von endometriose |
| WO2000059547A2 (en) * | 1999-04-02 | 2000-10-12 | Center For Molecular Medicine And Immunology | Method of detecting endometriosis |
| WO2000063675A1 (en) | 1999-04-16 | 2000-10-26 | Bioincept, Inc. | Identification of a serum marker for endometriosis |
| WO2000075321A2 (en) * | 1999-06-03 | 2000-12-14 | Curagen Corporation | Polynucleotides and membrane-bound polypeptide encoded thereby |
| EP1238104A2 (en) | 1999-11-03 | 2002-09-11 | Metris Therapeutics Limited | Agents implicated in endometriosis |
| GB0004232D0 (en) | 2000-02-24 | 2000-04-12 | Zeneca Ltd | Diagnostic method |
| ES2336817T3 (es) * | 2000-02-25 | 2010-04-16 | Siemens Healthcare Diagnostics Inc. | Marcadores relacionados con la endometriosis y usos de los mismos. |
| JP2003532078A (ja) * | 2000-04-19 | 2003-10-28 | リサーチ コーポレイション テクノロジーズ，インコーポレイテッド | 子宮内膜症の診断アッセイ |
| WO2001079846A2 (en) * | 2000-04-19 | 2001-10-25 | Research Corporation Technologies, Inc. | Diagnostic assay for endometriosis |
| DE10048633A1 (de) | 2000-09-25 | 2002-04-18 | Schering Ag | Methode zur in vitro Diagnostik von Endometriose |
| US6780594B2 (en) * | 2000-09-25 | 2004-08-24 | Schering Aktiengesellschaft | Method for in vitro diagnosis of endometriosis |
| WO2002068579A2 (en) | 2001-01-10 | 2002-09-06 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
| AU2002320630A1 (en) * | 2001-07-17 | 2003-03-03 | University Of Florida | Detecting and treating reproductive tract disorders |
| AU2003295328A1 (en) * | 2002-10-02 | 2004-04-23 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| WO2004087874A2 (en) | 2003-03-28 | 2004-10-14 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
| WO2005019258A2 (en) * | 2003-08-11 | 2005-03-03 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US6843673B1 (en) * | 2004-04-30 | 2005-01-18 | Speed Tech Corp. | Coaxial connector structure |
-
2004
- 2004-07-07 US US10/887,540 patent/US20060008876A1/en not_active Abandoned
-
2005
- 2005-06-30 EP EP05254121A patent/EP1614692B1/en not_active Expired - Lifetime
- 2005-06-30 DE DE602005014828T patent/DE602005014828D1/de not_active Expired - Lifetime
- 2005-06-30 AT AT05254121T patent/ATE433462T1/de not_active IP Right Cessation
- 2005-06-30 ES ES05254121T patent/ES2326324T3/es not_active Expired - Lifetime
- 2005-06-30 NZ NZ541063A patent/NZ541063A/en not_active IP Right Cessation
- 2005-07-04 AU AU2005202925A patent/AU2005202925A1/en not_active Abandoned
- 2005-07-05 CA CA002509632A patent/CA2509632A1/en not_active Abandoned
- 2005-07-06 JP JP2005197432A patent/JP2006051019A/ja active Pending
-
2006
- 2006-11-06 US US11/593,693 patent/US20070141600A1/en not_active Abandoned
- 2006-11-06 US US11/593,975 patent/US20070178528A1/en not_active Abandoned
- 2006-11-06 US US11/593,874 patent/US20080153106A1/en not_active Abandoned
-
2009
- 2009-07-15 US US12/460,255 patent/US7879562B2/en not_active Expired - Fee Related
- 2009-07-22 US US12/460,724 patent/US7981626B2/en not_active Expired - Fee Related
-
2011
- 2011-03-03 US US13/040,130 patent/US8030007B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7598843B2 (ja) | 腎疾患及び歯周疾患を検出及び診断するための方法及び組成物 | |
| KR102019008B1 (ko) | 메르스 코로나바이러스 뉴클레오캡시드 융합 단백질을 이용한 메르스 코로나바이러스 검출 방법 | |
| JP2010514805A5 (enExample) | ||
| JP2004512022A5 (enExample) | ||
| JP2004512824A5 (enExample) | ||
| JP2002528140A5 (enExample) | ||
| RU2016149596A (ru) | Новые полипептиды со специфическим связыванием и пути их применения | |
| JP2001511347A5 (enExample) | ||
| JP2012509295A5 (enExample) | ||
| JP2005519608A5 (enExample) | ||
| JPH1099087A5 (enExample) | ||
| JP2019527033A5 (enExample) | ||
| JP2006051019A5 (enExample) | ||
| JP5712513B2 (ja) | ヒトサイトメガロウイルス感染の検出方法 | |
| JP2003531634A5 (enExample) | ||
| JP2003510078A5 (enExample) | ||
| JP2009517015A5 (enExample) | ||
| JP2009525741A5 (ja) | HERV−W干渉群に属するウィルスの包膜とhASCT受容体との間の相互作用に必要なペプチド領域からなるペプチド | |
| JP2011528799A5 (enExample) | ||
| CN101477125B (zh) | 诊断结核病的基于结核杆菌抗原性多肽的组合物 | |
| JP2005516604A5 (enExample) | ||
| JP2008509659A5 (enExample) | ||
| JP2005528894A5 (enExample) | ||
| JP2004500055A5 (enExample) | ||
| JPH0772150A (ja) | ＩｇＥの測定方法 |